Unexpected Cataract Formation Following Valproate Treatment: A Case Report

Area of Science:

• Ophthalmology
• Psychiatry
• Pharmacology

Background:

• Valproic acid (VPA), also known as sodium valproate, is widely prescribed for psychiatric conditions, particularly bipolar disorder.
• Common VPA side effects are well-documented, but ocular adverse events, specifically cataracts, are exceptionally rare.
• Existing literature suggests a potential link between long-term VPA use and cataract formation in a limited number of cases.

Observation:

• This case report details an unusual instance of cataract development.
• The patient was undergoing treatment with valproic acid.

Findings:

• Long-term use of valproic acid has been linked to cataract formation in a limited number of studies.
• Cataract development is an exceedingly rare side effect of VPA therapy.

Implications:

• Patients on long-term VPA treatment should undergo regular ophthalmological examinations.
• Prompt recognition of visual disturbances is crucial for managing potential VPA-induced cataracts.
• This highlights the importance of monitoring for rare adverse drug reactions.